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Abstract
Immune thrombocytopenia purpura (ITP) may need
splenectomy after failure of medical treatment. The aim of
this study was to explore the outcome of splenectomy in
chronic ITP and to point out factors which can predict
better response to splenectomy. This retrospective chart
review was conducted at the Aga Khan University
Hospital, Karachi, and comprised adult patients who
underwent splenectomy for ITP from October 2005 to
December 2015. Of the 51 patients, 37(72.5%) were
females and 14(27.5%) were males. The overall median
age was 32 years (interquartile range: 18-65 years).
Complete response was seen in 43(84.3%) patients, 2(4%)
had response and 6(11.7%) had no response. Relapse rate
of ITP at 1 year was 4(8.8%). Multivariate analysis showed
that failure rate of splenectomy in the 41(80.4%) patients
aged <50 years was 3(7%) as opposed to 3(30%) in the
10(19.6%) patients aged >50 years (p=0.04). Splenectomy
was found to be a safe and effective option for treatment
of ITP. Young age at the time of surgery was associated
with good response to surgery.
Keywords: Idiopathic thrombocytopenic purpura,
Splenectomy, Response, Platelet.
Introduction
Immune thrombocytopenia purpura (ITP), also known as
idiopathic thrombocytopenia purpura, is a
haematological disorder in which there is premature
destruction of platelets. The disease is characterised by
peripheral thrombocytopenia, normal spleen and the
absence of other causes of decrease in platelets.1 The
disease can be categorised as acute ITP, defined as
thrombocytopenia occurring for <6 months, and often
occurs in children and young adults with no sex
predilection and is usually resolved spontaneously, or
chronic idiopathic ITP, which is more common in adults
aged 20-40 years, lasting >6 months with more cases in
female, and very uncommon spontaneous remission.2
The diagnosis of chronic ITP is usually a diagnosis of
exclusion. Many patients experience either no symptoms
or minimal bruising, whereas others experience severe
bleeding, which may include gastrointestinal bleeding,
extensive skin and mucosal haemorrhage, or intracranial
haemorrhage. The management of chronic ITP starts from
observation to corticosteroids-based therapy, use of
immunosuppressant and thrombopoietin (TPO)-receptor
agonist, and eventually splenectomy when medical
management fails or is contraindicated. Although the
precise mechanism of splenectomy in chronic ITP is still
not known, it is believed that in ITP spleen is the site of
autoantibodies production against platelets and
eventually these antibodies-coated platelets are
destroyed in the spleen. Hence, if the spleen is removed,
platelets will remain able to survive in circulation. But
platelets can also be removed from the liver or
combination of liver and spleen, so splenectomy is not
always successful. Much work is being done to see
response of ITP to splenectomy before surgery3 but to
date there is no proven data in this regard.
The current study was planned to see the response of
splenectomy in chronic ITP and to find out factors which
can predict good response.
Methods and Results
This retrospective chart review was conducted at the Aga
Khan University Hospital (AKUH), Karachi, Pakistan, and
comprised patients having undergone splenectomy for
ITP from October 2005 to December 2015. All patients
were evaluated and diagnosed to have chronic ITP by a
team of haematologists and after adequate medical
treatment they were referred for splenectomy as a
treatment option for ITP. All patients received
immunisation before surgery or two weeks after
splenectomy. For all patients, 1 mega unit of platelets was
arranged. Half volume of mega unit was transfused before
incision and half before clamping hilar vessels of spleen.
Intra-operative nasogastric (NG) tube and left sub-
diaphragmatic drain were placed in all patients. All
patients were kept in high dependency unit for one day
after surgery. NG tube was removed on the first post-
operative day while the drain was removed before
discharge if output remained <30ml/day. Aspirin was
started if the platelet count was >1,000x109. Patients'
platelets were checked post-operatively. To analyse
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outcome platelet count on first follow-up visit was
checked approximately 2 weeks after surgery to avoid any
false increase in the count because of pre-operative
transfusions. The patients' platelet count was checked at
1, 3, 6 and 12 months post-operatively. Response to
splenectomy was categorised according to American
Society of Haematology's guidelines of 20114 and
grouped as 'complete response' if post-operative platelets
count increased by more than 100x109, 'partial' if platelets
count remained between 30x109 to 100x109 and 'no
response' if it remained less than 30x109. Patients with
complete and partial response were grouped as
responders and the remainder as non-responders.
Relapse was defined as a decrease in platelet count to less
than 50×109/l5 after showing initial response to
splenectomy. A value of 50×109 was chosen because
above this level most patients do not require any form of
therapy. Data was analysed using SPSS 19.
Of the 51 patients, 14(27.5%) were males and 37(72.5%)
were females. The overall median age at the time of
splenectomy was 32 years (interquartile range: 18-65
years). Besides, 20(39.2%) patients underwent
spleenectomy within one year of diagnosis while
31(60.8%) patients were aware of their diagnosis for more
than one year. The mean platelets count before surgery
was 21.7 x 109±20x109. Of the total, 48(94.1%) patients
had received medical treatment prior to surgery as first
line of treatment and only 3(5.9%) patients directly
underwent surgery. Of the former, 25(49%) patients
received only steroids, whereas 23(45.1%) received
steroids and immunosuppressants.
In addition, 22(43.1%) patients underwent open
splenectomy, 22(43.1%) laparoscopies and 7(13.8%)
required conversion from laparoscopic to an open
procedure. The mean length of hospital stay was 6±4
days. Complete response was achieved in 43(84.3%)
patients, whereas response was noticed in 2(3.9%) and no
response in 6(11.7%) patients. Only 1(2%) patient expired
because of post-operative sepsis. Complications among
patients included intra-abdominal collection 2(3.9%),
post-operative chest infection 4(7.8%) and post-operative
haemorrhage requiring pack cells transfusion in 8(15.7%)
patients. Moreover, 4(7.8%) patients showed relapse at
overall follow-up of 1 year and were labelled as refractory
to splenectomy. Normal size spleen was found on
histopathology in all patients (Table-1).
Of all, 45(88.2%) patients were responders and 6(11.8%)
were non-responders. Of the 41(80.4%) patients aged <50
years, 38(92.7%) were responders and 3(7.3%) were non-
responders, whereas of the 10(19.6%) patients aged>50
years, 7(70%) were responders and 3(30%) were non-
responders (p=0.046). Of the 39(76.5%) patients having
pre-operative platelets count of <25,000, 33(84.6%) were
responders and 6(15.4%) were not, whereas all of the
12(23.5%) patients who had platelets count of >25,000
were responders (p=0.148) (Table-2).
Conclusion
This retrospective study at a single institute showed a
response rate of 84.3% to splenectomy and a mean
increase in platelets in responders after 1 year was
242.8x109 requiring no further treatment in these
patients. Moreover, 8.8% patients had relapsed with an
initial increase in platelets but after 6 months of surgery, it
decreased to less than 50x109. These patients required
additional medical treatment. Besides, 11.7% patients had
no response to splenectomy. These patients had no
increase in platelets at all. A similar kind of study done in
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Table-1: Outcomes of splenectomy.
Variable Frequency
Mean length of hospital stay 6±4 days
Mortality 1(1.96%)
Complications
Abdominal collection 2(3.92%)
Chest infection 4(7.8%)
Need for packed cell transfusion 8(15.6%)
Outcome
Complete response 43(84.3%)
Partial response 2(4%)
No response 6(11.7%)
Relapse at 1 year 4 (8.8%)
Table-2:Multivariate Analysis for predictive factors for Response to Splenectomy.
Variables Responders Non responders P value
n=44 n=6
Gender
Male 11 (78.6%) 3 (21.4%)
Female 33 (91.9%) 4 (8.1%) 0.18
Age
<50 years 38 (92.6%) 3 (7.4%)
>50 years 7 (70%) 3 (30%) 0.046
Timing of surgery
<1 year 16 (80%) 4 (20%)
>1 year 29 (93.5%) 2 (6.5%) 0.143
Preoperative platelets
<25000 33 (84.7%) 6 (15.3%)
>25000 12 (100%) 0 (0%) 0.148
Symptomatic 9 (100%) 0 (0%)
Asymptomatic 36(85.8%) 6 (14.2%) 0.227
Prior Medical management
No or single medical therapy 27(93.1%) 2(6.9%)
Multimodal therapy 18 (82%) 4 (18%) 0.215
six European haematology centres6 showed overall
response of 88%, a Italian study7 reported a rate of 86%,
whereas a study conducted in South Korea8 showed a
response rate of 73%. These results are quite comparable
to our study which had overall response of 84.3%.
In our study, when the variables of responders and non-
responders were compared, age below 50 years was
statistically significant (p=0.04) for better response after
splenectomy. This factor has been found persistently
significant in literature in previous studies as well. A
systematic review9 in 2004 showed better outcome of
splenectomy in younger age group of 32 to 51 years.
The current study was a retrospective audit with a small
number of patients over 10 years showing that disease is
not much prevalent in our part of world. Our study
showed that the response rate to splenectomy in our
population was better. The exact aetiology of this better
response is not known, but it may be because of genetic
or autoimmune factors which need to be looked at, as
these may give us clue to improving treatment results in
non-responders.
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